Lorna Brudie, DO
Gynecologic Oncology · Orlando, FLNPI 1942265517
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 30 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 21.8% — the pattern of someone who eats at a lot of different presentations. 2024 is the largest year on record at $675, 5.4 times the $126 reported in 2019. That places this record below the midpoint for gynecologic oncology clinicians in FL, where the typical reported total is $2,602.
Across 30 payments — averaging $57.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Myriad Genetic Laboratories, Inc.$374
- Conmed Corporation$200
- GSK$171
- Seagen Inc.$147
- Hologic Sales And Service, LLC$140
- AstraZeneca$130
- plus $552 from 12 others
Across 42 payments — averaging $320.14 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Merck$13K
What the payments were for
- Food & beverage$1,713100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Myriad Genetic Laboratories, Inc. | 5 | $374 |
| Conmed Corporation | 2 | $200 |
| GSK | 4 | $171 |
| Seagen Inc. | 2 | $147 |
| Hologic Sales And Service, LLC | 1 | $140 |
| AstraZeneca | 2 | $130 |
| Biom'up France SAS | 1 | $126 |
| Jazz Pharmaceuticals Inc. | 1 | $100 |
| BD | 1 | $78 |
| Applied Medical Resources Corporation | 1 | $77 |
| Merck | 2 | $40 |
| AbbVie | 2 | $31 |
| Genentech USA, Inc. | 1 | $20 |
| Smith+Nephew | 1 | $20 |
| Virtus Pharmaceuticals LLC | 1 | $18 |
| Amgen | 1 | $15 |
| Medtronic | 1 | $14 |
| Johnson & Johnson | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PreciseTumor$151
- HORIZON A$140
- HemoBlast Bellows$126
- VCARE$125
- AIRSEAL$125
- TIVDAK$125
- LYNPARZA$113
How this compares
$1,713 in reported general payments places this provider in the 40th percentile of 117 gynecologic oncology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 18 | $11,224 |
| Estradiol | 24 | $990 |
| Dexamethasone | 11 | $233 |
| Gabapentin | 16 | $127 |
| Misoprostol | 16 | $51 |
| Lorazepam | 20 | $36 |
| Fluconazole | 12 | $31 |
Paid to pharmacies, not to this prescriber.
Other gynecologic oncology in Orlando
- Robert HollowayOrlando$432K
- Shelly SewardOrlando$349K
- Nathalie McKenzieOrlando$223K
- Jessica KennardOrlando$39K
- Christopher BryantOrlando$28K
- Veronica SchimpOrlando$5K
- James KendrickOrlando$3K
- Bradley MonkWest Palm Beach$2.5M
- Martin MartinoJacksonville$957K
- Brian SlomovitzFort Lauderdale$519K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.